Merck KGaA offers a series of grants to stimulate innovative research

| By | Merck KGaA, R&D

In celebrating its 350th anniversary, Merck KGaA (Darmstadt, Germany) offers a series of research grants to stimulate innovative research in challenging areas of future importance.

Merck KGaA intends to provide several research grants of up to 350,000 per year for 3 years in various research areas with the option of extension or expansion.

The main focus areas for research include: drug discovery, synthetic biology, materials & solutions and digitalization/computing.

Researchers from around the world may apply for the grants. The research proposed for the grant must not involve interventional clinical research and must not involve the testing of competitors’ products. The application form can be found here.

All selected applicants will be invited to a three day workshop after signature of a confidential disclosure and workshop participation agreement to discuss and optimize a more detailed confidential research proposal further together with Merck scientists.

At the end of the workshop participants will present their optimized research proposal and the winning applicants will be selected by Merck. Merck will then enter into bilateral collaboration agreements with the winning recipients to enable pay-out of the research grant and project start in 2019.

SOURCE: merck kgaa
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.